Delta-thalassemia due to a mutation in an erythroid-specific binding protein sequence 3' to the delta-globin gene.

We have previously described a family of Northern Sardinian descent in which the propositus was affected by thalassemia major resulting from compound heterozygosity for codon 39 nonsense mutation and the beta +IVS II nt 745 mutation and in which all heterozygotes for the beta +IVS II nt 745 mutation had normal hemoglobin (Hb) A2 levels. To define the reasons for normal HbA2 levels in otherwise typical beta-thalassemia heterozygotes, we cloned and sequenced the delta-thalassemia gene in cis to the beta +IVS II nt 745 mutation. The sequence analysis showed a single nucleotide substitution (G----A) at position 69 nts (delta +69) downstream to the polyA addition site. Dot blot analysis with an oligonucleotide probe complementary to the delta +69 mutation detected this mutation in several heterozygotes for the beta +IVS II nt 745 mutation from the proband's family, but failed to show it either in a group of normal individuals of the same origin or in nonrelated heterozygotes for the beta +IVS II nt 745 mutation of the same or different descent from the proband. The delta +69 (G----A) mutation may be responsible for the low delta-globin output from the beta +IVS II nt 745 chromosome or could be a silent polymorphism not affecting the function of the delta-globin gene. The normal G at position 69 is part of a sequence very similar to the core DNA (A/T)GATA(A/G) motif (GATA box) that is a binding site for the GATA-1 protein. Gel-retardation assay has shown that a DNA fragment containing the GATA motif with the G----A at position +69 has increased binding affinity for erythroid-specific DNA binding protein(s) as compared with the wild-type sequence. These findings may suggest that the delta +69 mutation is responsible for the deficient function of the in cis delta-globin gene.

[1]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Reitman,et al.  An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H A Erlich,et al.  Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Crothers,et al.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. , 1981, Nucleic acids research.

[5]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[6]  F. Grosveld,et al.  Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Nucleic acids research.

[7]  M. Goossens,et al.  DNA analysis in the diagnosis of hemoglobin disorders. , 1981, Methods in enzymology.

[8]  P. Romeo,et al.  Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Orkin,et al.  Increased γ-globin expression in a nondeletion HPFH mediated by an erythroid-specif ic DNA-binding factor , 1989, Nature.

[10]  F. Grosveld,et al.  The human beta-globin gene 3' enhancer contains multiple binding sites for an erythroid-specific protein. , 1988, Genes & development.

[11]  M. Reitman,et al.  Mutational analysis of the chicken beta-globin enhancer reveals two positive-acting domains. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Shih-Feng Tsai,et al.  Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells , 1989, Nature.

[13]  F. Collins,et al.  Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin , 1988, Molecular and cellular biology.

[14]  R. Mantovani,et al.  The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. , 1988, Nucleic acids research.

[15]  R. Mantovani,et al.  A protein factor binding to an octamer motif in the gamma-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells. , 1987, Nucleic acids research.

[16]  J. D. Engel,et al.  Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. , 1990, Genes & development.